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Abstract
Background: Although genes play a key role in many complex diseases, the specific genes involved
in most complex diseases remain largely unidentified. Their discovery will hinge on the
identification of key sequence variants that are conclusively associated with disease. While much
attention has been focused on variants in protein-coding DNA, variants in noncoding regions may
also play many important roles in complex disease by altering gene regulation. Since the vast
majority of noncoding genomic sequence is of unknown function, this increases the challenge of
identifying "functional" variants that cause disease. However, evolutionary conservation can be used
as a guide to indicate regions of noncoding or coding DNA that are likely to have biological
function, and thus may be more likely to harbor SNP variants with functional consequences. To
help bias marker selection in favor of such variants, we devised a process that prioritizes annotated
SNPs for genotyping studies based on their location within Multi-species Conserved Sequences
(MCSs) and used this process to select SNPs in a region of linkage to a complex disease. This
allowed us to evaluate the utility of the chosen SNPs for further association studies. Previously, a
region of chromosome 1q43 was linked to Multiple Sclerosis (MS) in a genome-wide screen. We
chose annotated SNPs in the region based on location within MCSs (termed MCS-SNPs). We then
obtained genotypes for 478 MCS-SNPs in 989 individuals from MS families.
Results: Analysis of our MCS-SNP genotypes from the 1q43 region and comparison to HapMap
data confirmed that annotated SNPs in MCS regions are frequently polymorphic and show subtle
signatures of selective pressure, consistent with previous reports of genome-wide variation in
conserved regions. We also present an online tool that allows MCS data to be directly exported
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to the UCSC genome browser so that MCS-SNPs can be easily identified within genomic regions
of interest.
Conclusion: Our results showed that MCS can easily be used to prioritize markers for follow-up
and candidate gene association studies. We believe that this novel approach demonstrates a
paradigm for expediting the search for genes contributing to complex diseases.
Background
Adding to the challenge of disease gene discovery is the
scale of genotyping that is required to conduct association
studies in regions demonstrating linkage. Because the fol-
low-up analysis of genomic linkage screen results often
entails performing candidate gene analyses within a
selected genomic region of interest, the number of neces-
sary genotyping assays to thoroughly test candidate genes
within each region quickly becomes very large and often
cost prohibitive. New approaches to increase effectiveness
of genotyping studies are clearly needed. With this in
mind, we provide a novel approach that incorporates evi-
dence from positional and informatic approaches to expe-
dite follow-up of candidate regions. The utility of
combining these approaches is evident in several recent
studies for complex genetic disorders. For example, the
emerging concept of "genomic convergence" suggests that
parallel investigations of genetic linkage, association, and
expression data will speed disease gene discovery [1].
Application of this process to identify and prioritize can-
didate genes on chromosome 10 in Alzheimer disease and
Parkinson's disease recently led to the successful identifi-
cation of two genes significantly associated with these dis-
eases [2].
An area of current interest in genomics and disease gene
discovery concerns information that can be gained from
assessing evolutionary sequence conservation between
species. Such sequences that have remained similar across
the millions of years of evolution are believed to indicate
regions of biological function [3]. Researchers are increas-
ingly integrating knowledge of conserved sequences in the
selection of SNPs for genetic studies–whether it is to iden-
tify evidence of coding regions, potential splice sites, or
regulatory regions [4,5]. In this capacity, conservation can
be used as a putative annotation for genomic regions that
may have functional importance, even when the precise
nature of their function is lacking. This conserved
sequence approach has several potential advantages. For
example, since noncoding regulatory elements that con-
trol neighboring genes can be dispersed across large areas
devoid of coding sequences, conserved elements might
help discriminate functional regions within large noncod-
ing areas that might not share linkage disequilibrium with
coding markers [6-8]. Conservation can also indicate cod-
ing regions that may lack strong annotation support, such
as alternatively spliced exons, RNA genes, "novel" genes
with no homology to other gene families, or genes
expressed at very low levels.
A current challenge to genetic association studies is that it
is usually not practical to genotype all SNPs in a region of
interest. Linkage disequilibrium (LD) patterns can be
exploited to identify subsets of "tag" SNPs that can serve
as surrogates for detecting associations driven by func-
tional SNPs that are in LD with tag SNPs; however, the sta-
tistical power of this approach depends on the degree of
LD between markers, and decreases as LD decreases. Test-
ing "functional" SNPs directly should help maximize the
likelihood of detecting significant associations with dis-
ease phenotypes. By using conservation to prioritize SNPs,
the odds may be increased that SNPs impacting the phe-
notype in question will actually be genotyped. For exam-
ple, variation in transcriptional levels for key genes can
play a significant role in disease risk [5,9]. SNPs in non-
coding cis-regulatory sequences, such as enhancers,
repressors, or chromatin structural regulators, might con-
tribute to the genetic component of this process by mod-
ulating transcriptional output. It is reasonable to predict
that SNPs within conserved regions may be more likely to
have phenotypic effects than SNPs in nonconserved DNA.
There are currently several publicly available tools to
detect evolutionarily conserved sequences across large
genomic regions by performing sequence alignments
[10,11]. However, simple pair-wise sequence compari-
sons have drawbacks for use as a systematic approach in
prioritization of conserved regions. With a relatively large
region, sequence alignment between any two mammalian
species can provide too much aligning sequence, resulting
in the over-identification of sequences that are not actu-
ally preserved due to selective processes and are thus less
likely to be functional [12]. Conversely, sequence align-
ment between more divergent species (e.g. between
human and Fugu) can provide too little aligning sequence,
resulting in the identification of only highly conserved
protein-coding regions, while most noncoding regions are
unalignable. Fortunately, new alignment methods that
compare sequences from multiple species have been
developed to minimize these drawbacks. By comparing
sequence from three or more vertebrate species, human
sequences that are likely to be functional can be detected
with improved sensitivity and specificity [13].BMC Genomics 2007, 8:266 http://www.biomedcentral.com/1471-2164/8/266
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Recently, an algorithm for detecting multi-species con-
served sequences (MCS) has been optimized for scoring
multi-species alignment data across large genomic regions
[14]. This allows MCS scores to be assigned across any
human genomic region, provided that sequences from
multiple species have been aligned. While multiple spe-
cies are used for comparison, a sequence block can be
assigned a high MCS score even if not all the compared
species show alignment to the region. This makes the MCS
method robust when comparing draft genomes, and for
identifying elements that may be conserved only within
subgroups of species (e.g. within mammals only). In
other words, an MCS may be classified as such even if it is
not conserved across all the species in the comparison.
MCS analysis incorporates genome sequence alignment
data from multiple species in order to assign MCS scores
to 50-base pair windows across the human genome. Using
this tool, one can identify all sequences in a region of
interest that have MCS scores above a defined threshold
(e.g., in the top 5% of genome-wide MCS scores) [14].
Substantial portions of multi-species conserved sequences
are in noncoding regions. Previous analyses suggest that
approximately the top 4–7% of MCS scores are very likely
to indicate regions of human DNA undergoing evolution-
ary selection [14]. This threshold also detects the vast
majority of coding exons, yet still detects many noncoding
regions. This highlights the importance of MCS in detect-
ing potentially functional sequences within relatively
large genomic regions (e.g. several Mb) without relying
solely on gene annotation.
We have formulated a systematic approach to prioritize
SNP markers to be genotyped for association studies in
any target region, with a specific application to the 1q43
linkage region in MS [15,16]. This approach incorporates
MCS analysis to prioritize markers within MCSs, termed
MCS-SNPs, for high-throughput genotyping. Here we
show that annotated SNPs in MCSs were readily identified
and are frequently polymorphic. By comparing our find-
ings with publicly available data from the HapMap
Project [17] we confirm that MCSs have a slightly reduced
SNP density. We also provide an online tool and instruc-
tions to extract MCS-SNPs for any region of human DNA,
via the UCSC genome browser. Our data is consistent with
previous descriptions of human SNP variation in con-
served regions [18], suggesting the MCS tool is useful for
identifying these SNPs. These findings indicate that con-
servation is a useful guide for selecting SNPs that may
reside in biologically functional elements, particularly for
those in noncoding regions.
Results
We analyzed SNPs in a ~ 7.0-Mb region of human 1q43
that showed suggestive linkage to multiple sclerosis (MS)
[15,16]. This region was bounded by SNPs rs10925296
and rs1319790 (encompassing chr1:233,515,650-
240,494,277 of human Build 35). We initially defined
MCS in this region based on a "4-way" species compari-
son (see Methods). The majority (478/768) of SNPs that
we subsequently genotyped were chosen from within
MCS elements (see Methods). An additional 290 SNPs in
nonconserved regions were added to provide additional
coverage across the 1q43 region. In all, 479 SNPs were
within boundaries of known genes and the remaining 289
markers were in intergenic regions. All SNPs were geno-
typed in our sample population of 173 families (989 indi-
viduals). Analyses to test for potential association(s)
between these SNPs and multiple sclerosis will be pre-
sented elsewhere.
In order to screen as many MCS-SNPs as possible, we
selected MCS-SNPs for genotyping without regard to prior
validation status. We therefore examined the fraction of
our chosen MCS-SNPs and non-MCS-SNPs that demon-
strated polymorphism in our study population (Table 1).
Approximately 35–37% of SNPs within MCS regions were
monomorphic in our study population. Although the per-
centage of monomorphic SNPs located within non-MCS
regions was much less (8–15%), this was likely an artifact
of our bias in selection of non-MCS-SNPs. Non-MCS-
SNPs were chosen only if there was good prior bioinfor-
matics evidence supporting their validation; however,
prior validation was not a criteria used for selecting the
MCS-SNPs.
During our initial study, more genomic sequence data
from additional vertebrate species became available. Add-
ing species can potentially increase the sensitivity and spe-
Table 1: Descriptive breakdown of SNPs chosen for follow-up genotyping within the 7.0 Mb 1q43 region
Our Dataset 4-way comparison (%) 5-way comparison (%) 8-way comparison (%)
Total SNPs 768 (100%) 768 (100%) 768 (100%)
MCS-SNPs 478 (62%) 365 (48%) 337 (44%)
Polymorphic 311 (40%) 233 (30%) 213 (28%)
Monomorphic 167 (22%) 132 (17%) 124 (16%)
non-MCS-SNPs 290 (38%) 403 (52%) 431 (56%)
Polymorphic 268 (35%) 346 (45%) 366 (48%)
Monomorphic 22 (3%) 57 (7%) 65 (8%)BMC Genomics 2007, 8:266 http://www.biomedcentral.com/1471-2164/8/266
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cificity of MCS analysis in detecting functional elements
[14]. Therefore, we retrospectively compared the fraction
of the MCS-SNPs defined by the "4-way" species compar-
ison that were still within MCS as defined by "5-way" and
"8-way" species comparisons (see Methods, Table 1).
Approximately 70% of MCS-SNPs identified by "4-way"
comparison (N = 478) were still within MCSs defined by
the "8-way" comparison (N = 337).
We examined the entire ~ 7.0-Mb region in greater detail.
Using data from the UCSC genome browser [19] (Build
35) we found over 28,200 distinct annotated SNPs in this
region. Of all bases in the 7.0-Mb region, 5.10% were
assigned MCS scores that meet the threshold for classifica-
tion as MCS based on the "8-way" comparison, indicating
an MCS density similar to the genome-wide average
(defined as the top 5%). However, only ~ 3.2% of the
annotated SNPs are within MCS elements. Thus, anno-
tated SNPs are less dense in MCS versus non-MCS
sequence. This is consistent with potential selection
against variation within regions of high conservation, as
observed in a previous whole-genome analysis [18].
These findings indicated that despite the modest reduc-
tion in SNP density within MCS, many polymorphic
MCS-SNPs were validated in our sample population.
Given the recent finding that in general, SNP minor allele
frequencies (MAFs) are reduced in conserved sequence
[18], we examined HapMap data within the 7.0-Mb inter-
val to determine whether our MCS-SNPs exhibited
reduced MAFs [20]. Rates of observed monomorphism
were examined, as this could reflect either an excess of
very rare alleles in MCS, or that truly polymorphic SNPs
were more rare in MCS. Data from the HapMap CEU pop-
ulation (30 trios of northern and western European ances-
try collected by the Centre d'Etude du Polymorphisme
Humain (CEPH)) was used for comparison, as our sample
contained almost exclusively U.S. Caucasian individuals.
We counted the total number of HapMap CEU SNPs (N =
11,076 SNPs) falling in MCS regions defined by "8-way"
comparisons (N = 28,243 SNPs), and then further subdi-
vided these based on location in or outside exons and
whether they were polymorphic or monomorphic in the
HapMap CEU population (Table 2). Within the exons of
this region, MCS-SNPs had an average MAF of 0.20 and
51% monomorphism rate, while non-MCS-SNPs in exons
had an average MAF of 0.27 and 19% monomorphism
rate. Thus, as expected exonic MCS-SNPs had reduced
MAF and increased monomorphism. Since variation is
known to be reduced in coding sequence, we examined
the non-exonic SNPs. Similar trends were observed,
though less pronounced than in exonic SNPs. Non-exonic
MCS-SNPs had an average MAF of 0.22 and monomor-
phism rate of 37%, while non-exonic/non-MCS SNPs had
an average MAF of 0.23 and a 32% monomorphism rate.
The difference in MAFs was not significant by chi-square
test (not shown), although the trend reflects genome-wide
observation [18]. However, the increased rate of mono-
morphism of MCS-SNPs in non-exonic regions was signif-
icant (Table 3).
An MCS calculator is now available to provide easier
access to genome-wide MCS data [21]. This resource
allows MCS elements for a human genomic region of
interest to be rapidly exported to the UCSC genome
browser as a "custom" track, such that SNPs within MCS
can be quickly identified (Figure 1). Lists of MCS-SNPs
can then be easily retrieved, or visualized on the browser
(Figure 2). Detailed instructions, for navigating the Web-
MCS and UCSC websites in order to extract MCS-SNPs,
are provided [see Additional File 1].
Since noncoding MCS-SNPs could affect gene regulation,
it may be of interest to prioritize analysis of SNPs that dis-
rupt putative transcription factor binding sites (TFBS). The
UCSC browser "TFBS Conserved" track displays predicted
TFBS present in regions of human/mouse/rat conserva-
tion [19]. This track could be used as an independent SNP
filtering mechanism; alternatively, as many predicted sites
overlap with MCS it could easily be used to further prior-
itize MCS-SNPs. For example, in the 7 Mb chromosome 1
region described here 1359 conserved TFBS sites are pre-
dicted, of which 889 (65%) are within 8-way MCS
regions. For any region of interest, a file of MCS-SNPs
could be extracted as a UCSC-ready custom track using the
UCSC Table Browser [see Additional File 1], and immedi-
ately used to identify the subset of MCS-SNPs that overlap
conserved TFBS. In the chromosome 1 region 30 HapMap
SNPs were found to overlap TFBS; of these, 15 are also
within 8-way MCS.
Table 2: Descriptive breakdown of HapMap CEU SNP data 
across the 1q43 7.0 Mb region
All annotated SNPs 
(Build 35) Chr1: 
233515650-240494277
CEU population: 
genotyped SNPs 
(8-way comparison)
Total SNPs 28243 11076*
exonic SNPs 208 74
MCS-SNPs 130 47
Polymorphic NA 23 (MAF = 0.20)
Monomorphic NA 24
non-MCS-SNPs 78 27
Polymorphic NA 22 (MAF = 0.27)
Monomorphic NA 5
non-exonic SNPs 28035 11002
MCS-SNPs 776 414
Polymorphic NA 259 (MAF = 0.22)
Monomorphic NA 155
non-MCS-SNPs 27259 10587
Polymorphic NA 7241 (MAF = 0.23)
Monomorphic NA 3346BMC Genomics 2007, 8:266 http://www.biomedcentral.com/1471-2164/8/266
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Actual coverage of MCS-SNPs in genotyping studies
depends on the coverage of working genotyping assays.
For the latter reason, the coverage of MCS-SNP assays in
existing whole-genome SNP genotyping platforms is of
interest. For both chromosomal regions, we determined
the fraction of MCS-SNPs that are in existing Affymetrix
500 K SNP chips and in the Illumina 300 K assay set
(Table 4). Interestingly, coverage for these assay sets
ranges from roughly 4–12% but was roughly twice as great
in the chromosome 8 region, independent of platform.
Therefore, the large majority of MS-SNPs are not directly
represented in these genotyping platforms. For genotyp-
ing genomic regions of interest, the effective association
coverage of MS-SNPs with these assay sets will be a func-
tion of the MS-SNP representation for the assay set used,
the ability of assays in the set to "tag" LD across markers,
and the LD structure of the population in question.
Since LD can be used to select tag SNPs that provide sur-
rogate information for groups of SNPs having shared LD,
it is reasonable to question whether prioritization of MCS
SNPs is useful if LD tagging strategies can "cover" MCS
regions effectively. To assess this, we used the Tagger tool
[22] through the HapMap website [20] to obtain HapMap
CEU tag SNPs for the 7 Mb region (using MAF > = 0.05, r2
> = 0.8). This analysis was also performed for a randomly
chosen 5 Mb region on chromosome 8 roughly centered
on the GDF6  gene (build hg17, chr8: 95,000,001–
100,000,000). This region contains a higher gene density
than the 7 Mb chromosome 1 region (30 RefSeq anno-
tated genes; ~ 170 kb/gene) but slightly lower 8-way MCS
coverage (3.73%). For the chromosome 1 and 8 regions,
respectively, 242 and 146 SNPs fell in MCS; of these, 34
(14%) and 13 (9%) did not share LD with any other SNPs
and were thus not captured by other tags. Therefore, while
a large majority of HapMap-genotyped MCS-SNPs are
captured by tag SNPs obtained by these parameters from
the CEU data set it may be of interest to augment tagging
strategies by including "uncaptured" MCS-SNPs in geno-
typing studies.
Discussion
Here we show that polymorphic SNPs can be readily iden-
tified within conserved noncoding regions, and that SNP
selection based on conservation data is an approach that
can be readily incorporated into genotyping projects.
Genetic association studies have typically placed heavy
emphasis on coding SNPs, with the idea that these are
more likely to have biological impact than noncoding
SNPs. SNP analysis in noncoding DNA has typically been
restricted to promoter regions, though conservation in
more distant noncoding regions is a widespread observa-
tion. Our approach prioritizes SNPs in conserved noncod-
ing and coding regions, since conservation is widely
accepted to correlate with function in either type of
sequence.
Although the density of MCS in the ~ 7.0-Mb region is
similar to the genome-wide average, the number of exonic
bases and total genes per kb are below genome averages.
The region contains 17 genes based on RefSeq annotation
[19], which is far below the genome average of approxi-
mately 9 genes per Mb [23]. Notably, this region contains
several large genes (RYR2, 791 kb; RGS7, 582 kb; PLD5,
436 kb) as well as a "gene desert" of ~ 1.5-Mb. Based on
RefSeq annotation, 51.3% of genomic bases in the inter-
Scheme for identifying MCS-SNPs Figure 1
Scheme for identifying MCS-SNPs.
Table 3: Comparison of monomorphic vs. polymorphic non-exonic SNPs, in HapMap CEU (8-way MCS vs. non-MCS)
Polymorphic SNPs Monomorphic SNPs Chi-square p-value
Non-exonic MCS 259 155 6.25 0.012
non-MCS 7241 3346
Exonic MCS 23 24 7.62 0.006
non-MCS 22 5BMC Genomics 2007, 8:266 http://www.biomedcentral.com/1471-2164/8/266
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val are spanned by transcription units, and 1.02% of bases
are within exons, less than the estimated genome-wide
fraction of coding bases (1.5%) [12]. Even with the con-
servative assumption that 100% of exon bases fall within
MCS elements, at least 4% of MCS bases must be in non-
coding MCS regions (see Results). Since not all exon bases
are in MCS regions, this is a minimal estimate. Thus, rela-
tive to the whole genome the 7.0-Mb interval has slightly
below average density of genes and exonic bases, but has
a fraction of noncoding MCS that is similar to genome-
wide estimates of noncoding conservation [12].
There are two similar hypotheses at play when discussing
variation in regions of conservation. The first is that
regions of conserved DNA sequence, whether coding or
noncoding, are likely to have biological function(s). The
extension of this idea is that when examining these
regions in suspected disease genes, functional variations
will be discovered that predispose to disease risk. How-
ever, a second hypothesis is that because conserved
regions are indeed likely to have important functions, var-
iants that persist within these regions are actually those
that are less likely to have functional effects, as variants
that impact function are likely to reduce fitness and be
subjected to negative selection pressure. This stems from
the concept that most perturbations in conserved
sequence will reduce reproductive fitness. These conflict-
ing hypotheses can be somewhat reconciled by the notion
that many genetic variants that predispose to complex,
common diseases in the present day may have had negli-
gible effects on reproductive fitness in recent human evo-
lution. Regions of high conservation harbor biological
function and therefore are likely to be under selective con-
straint. New variants in these regions are often detrimen-
tal and thus less likely to persist in populations, which
may explain the increased rate of apparent monomor-
phism (or rare alleles) for MCS markers. However, some
persisting MCS variants may have phenotypic effects that
influence disease risk. Variants that alter potential TFBS
are particularly interesting and may be worthwhile to pri-
oritize, although the density of such MCS-SNPs was on
the order of one per gene in the chromosome 1 region.
However, since actual binding sites can deviate from the
predicted consensus and not all factor binding motifs are
known, not all "functional" SNPs that disrupt true bind-
ing sites will be identified with this approach.
For certain studies, different combinations of species
might be more desirable for classifying MCS. For example,
inclusion of additional mammals might be useful for
detecting functional elements that are not expected to be
present in other vertebrates. In fact, diseases that involve
the immune response (such as MS or lupus) might be con-
trolled by genes with a more recent or dynamic evolution-
ary history. We note that users can define MCS with
custom-generated sequence alignments based on species
Table 4: Coverage of 8-way MCS-SNPs in whole-genome assay sets
Chr1: 233,515,650-240,494,277 Chr8: 95,000,001–100,000,000
Total MCS-SNPs 906 382
within MCS:
Affymetrix 500 K Nsp SNPs 31 (3.4%) 29 (7.6%)
Affymetrix 500 K Sty SNPs 21 (2.3%) 14 (3.7%)
Total Affy500 K 52 (5.7%) 43 (11.7%)
Illumina 300 K 39 (4.3%) 32 (8.4%)
UCSC genome browser image showing position of MCS-SNPs in the vicinity of the EXO1 gene Figure 2
UCSC genome browser image showing position of MCS-SNPs in the vicinity of the EXO1 gene. After obtaining the subset of 
SNPs within MCS, the Table Browser function allows MCS-SNPs to be downloaded in table format or visualized as a custom 
track on the browser as shown here. Note several MCS-SNPs are in EXO1 5' flanking region, and in introns (e.g. rs4149896, 
rs2526698) as well as those in exons.BMC Genomics 2007, 8:266 http://www.biomedcentral.com/1471-2164/8/266
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data of their choice, using the WebMCS online resource
[24].
Since many MCS-SNPs are not represented in widely used
whole-genome genotyping platforms, the inclusion of
MCS-SNPs is particularly for candidate gene regions
where dense coverage of potentially functional SNPs is of
greater interest. For candidate genomic regions (or popu-
lations) that are characterized by low linkage disequilib-
rium, prioritizing MCS-SNPs may have additional value,
as markers are less likely to be effectively captured by tag-
ging strategies.
Conclusion
Our results are consistent with recent reports that SNP
density and derived (new) SNP allele frequencies are
slightly reduced in noncoding conserved regions as com-
pared to nonconserved regions [18]. Our findings also
confirm that inferences from genome-wide conservation
data can be usefully applied to SNP selection for fine-
mapping genetic studies. The MCS-SNP approach repre-
sents practical knowledge for choosing SNP markers and
can be integrated with current approaches for genotyping
studies to refine or follow-up regions or genes believed to
be involved in disease.
Methods
Subjects and phenotypes
This study involved genotyping 768 SNPs in a dataset of
173 multiple sclerosis families (989 individuals geno-
typed). Families were ascertained at the University of Cal-
ifornia at San Francisco (UCSF) as previously described
[15]. Of these 173 families, 91 families had previous evi-
dence for positive linkage to 1q43 [16]. Informed consent
was obtained for all subjects. This research was performed
under protocol #8692 as approved by Vanderbilt Univer-
sity Internal Review Board.
Molecular analysis
768 SNPs were chosen for genotyping by selecting SNPs
from the UCSC genome browser with significant prefer-
ence given to markers with an MCS score exceeding the
top 5% threshold (see below). The Illumina BeadArray™
platform was used for SNP genotyping. All genotyping
was performed by the Duke Genomics Resource Labora-
tory Core using the Illumina BeadArray™ platform.
For this study we used MCS scores that fall in the top 5%
of genome-wide MCS scores for 50-base pair sequences
[14], based on "4-way" genome-wide alignment between
human, mouse, rat, and chick genomes (see below).
Selection of SNPs in conserved regions was based on
informativeness (with preference given to SNPs with high
minor allele frequencies), validation (preference to SNPs
confirmed by multiple lines of evidence), location (pref-
erence to SNPs spaced at regular intervals), putative func-
tion (preference to SNPs in coding, splice site, and mRNA
UTR regions), and assay scores provided by Illumina
(preference to SNPs generating scores > 0.60). Illumina
scores were determined by an algorithm weighing a series
of factors to predict the success of each locus within an
OPA. Scores ranged between 0 and 1, with Illumina rec-
ommending selection of SNPs generating scores > 0.60.
Several SNPs located in 5% MCS regions were eliminated
from the study due to the nature of the variation preclud-
ing genotyping on the Illumina platform (e.g. insertion/
deletions or multiple mutation events leading to > 2 alle-
les) and/or the failure to generate an Illumina score >
0.60. Because elimination of these SNPs resulted in the
identification of fewer than 768 SNPs in conserved
regions, additional SNPs were selected from noncon-
served regions, with similar consideration for suitability
to the Illumina platform and to create an average spacing
of < 10 kb for the 768 SNPs in the ~ 7.0-Mb region of
interest. This density was chosen to make most efficient
use of the Illumina platform and may help to exploit link-
age disequilibrium for future association studies, based
on LD patterns in Caucasians [25]. Most markers fell
within intronic and intergenic areas.
Statistical analysis
We initially identified multi-species conserved sequences
(MCSs) through a "4-way" alignment of mouse, rat, and
chick genomic sequence to human chromosome 1q43
sequence (Build 35, chr1:233,515,650-240,494,277)
[14,21]. MCS regions were defined as those regions with
MCS scores falling in the top 5% of genome-wide scores.
This allowed us to identify 478 SNPs from MCS regions
that were amenable to genotyping on the Illumina plat-
form as described above. Since the time we initially chose
the markers, additional genome sequences for other
model organisms have been produced. Therefore we also
analyzed our SNPs using new MCS scores derived from
both "5-way" alignments of genomic sequences (human,
mouse, rat, chick, and Fugu) and "8-way" species align-
ments (human, chimp, mouse, rat, dog, chick, Fugu, and
zebrafish) (Margulies, unpublished). Currently, genome-
wide MCS data based on the "8-way" species comparison
can be obtained online [21].
HapMap CEU data from the international HapMap
project, were used to examine SNP data in the 1q43 region
(HapMap Data Rel#20/phaseII Jan06, on NCBI B35
assembly, dbSNP b125; [20]). Comparisons of numbers
of monomorphic and polymorphic markers in each group
were made using a Chi-square test for significance (Table
3). The UCSC browser TFBS conserved track was imple-
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